Your browser doesn't support javascript.
loading
An integrative analysis of non-coding regulatory DNA variations associated with autism spectrum disorder.
Williams, Sarah M; An, Joon Yong; Edson, Janette; Watts, Michelle; Murigneux, Valentine; Whitehouse, Andrew J O; Jackson, Colin J; Bellgrove, Mark A; Cristino, Alexandre S; Claudianos, Charles.
Afiliação
  • Williams SM; University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia.
  • An JY; Queensland Brain Institute, University of Queensland, Brisbane, Australia.
  • Edson J; Queensland Brain Institute, University of Queensland, Brisbane, Australia.
  • Watts M; Department of Psychiatry, University of California San Francisco, San Francisco, USA.
  • Murigneux V; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, USA.
  • Whitehouse AJO; Queensland Brain Institute, University of Queensland, Brisbane, Australia.
  • Jackson CJ; Queensland Brain Institute, University of Queensland, Brisbane, Australia.
  • Bellgrove MA; University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia.
  • Cristino AS; Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Claudianos C; Cooperative Research Centre for Living with Autism, Brisbane, Australia.
Mol Psychiatry ; 24(11): 1707-1719, 2019 11.
Article em En | MEDLINE | ID: mdl-29703944
ABSTRACT
A number of genetic studies have identified rare protein-coding DNA variations associated with autism spectrum disorder (ASD), a neurodevelopmental disorder with significant genetic etiology and heterogeneity. In contrast, the contributions of functional, regulatory genetic variations that occur in the extensive non-protein-coding regions of the genome remain poorly understood. Here we developed a genome-wide analysis to identify the rare single nucleotide variants (SNVs) that occur in non-coding regions and determined the regulatory function and evolutionary conservation of these variants. Using publicly available datasets and computational predictions, we identified SNVs within putative regulatory regions in promoters, transcription factor binding sites, and microRNA genes and their target sites. Overall, we found that the regulatory variants in ASD cases were enriched in ASD-risk genes and genes involved in fetal neurodevelopment. As with previously reported coding mutations, we found an enrichment of the regulatory variants associated with dysregulation of neurodevelopmental and synaptic signaling pathways. Among these were several rare inherited SNVs found in the mature sequence of microRNAs predicted to affect the regulation of ASD-risk genes. We show a paternally inherited miR-873-5p variant with altered binding affinity for several risk-genes including NRXN2 and CNTNAP2 putatively overlay maternally inherited loss-of-function coding variations in NRXN1 and CNTNAP2 to likely increase the genetic liability in an idiopathic ASD case. Our analysis pipeline provides a new resource for identifying loss-of-function regulatory DNA variations that may contribute to the genetic etiology of complex disorders.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Intergênico / Transtorno do Espectro Autista Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Intergênico / Transtorno do Espectro Autista Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Ano de publicação: 2019 Tipo de documento: Article